Gosset Calcium oxalate crystal formation Overview
Calcium oxalate crystal formation is a pathophysiological process where calcium and oxalate ions precipitate to form crystals, primarily in the urinary tract, leading to kidney stone formation and associated renal cell injury. The process is influenced by factors such as supersaturation, pH, energy input, and the presence of inhibitors or promotors of crystallization. In nature, calcium oxalate crystals serve physiological roles in plants and lichens, such as calcium regulation and protection, but in humans this process is predominantly associated with disease states. Therapeutic research is focused on designing molecules that inhibit crystal nucleation, growth, or aggregation to prevent kidney stone disease.
Mechanism of Action
Inhibition by surface modifiers (e.g., polyphosphates act by binding to crystal faces, occlusion within crystal lattice, and kinetic inhibition of growth and aggregation)
Biological Functions
Disease Associations
Safety Considerations
- Not applicable directly. Therapeutic challenges include preventing unwanted crystallization without systemic disturbances in calcium or oxalate metabolism.
Interacting Drugs
Associated Biomarkers
| Biomarker |
|---|
| Calcium oxalate crystals in urine (used to monitor kidney stone risk/formation) |
| Urinary supersaturation ratios of calcium and oxalate |